BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1054 related articles for article (PubMed ID: 15032383)

  • 1. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular characterization of non-syndromic retinal dystrophy due to c.175G>A mutation in ceroid lipofuscinosis neuronal 3 (CLN3).
    Chen FK; Zhang X; Eintracht J; Zhang D; Arunachalam S; Thompson JA; Chelva E; Mallon D; Chen SC; McLaren T; Lamey T; De Roach J; McLenachan S
    Doc Ophthalmol; 2019 Feb; 138(1):55-70. PubMed ID: 30446867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuronal ceroid-lipofuscinoses.
    Goebel HH
    J Child Neurol; 1995 Nov; 10(6):424-37. PubMed ID: 8576551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deterioration of visual quality and acuity as the first sign of ceroid lipofuscinosis type 3 (CLN3), a rare neurometabolic disease.
    Purzycka-Olewiecka JK; Hetmańczyk-Sawicka K; Kmieć T; Szczęśniak D; Trubicka J; Krawczyński M; Pronicki M; Ługowska A
    Metab Brain Dis; 2023 Feb; 38(2):709-715. PubMed ID: 36576693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.
    Kühl TG; Dihanich S; Wong AM; Cooper JD
    J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
    Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel in-frame mutation in
    Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
    Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
    [No Abstract]   [Full Text] [Related]  

  • 11. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
    Tokola AM; Salli EK; Åberg LE; Autti TH
    Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
    de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
    J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis.
    Wisniewski KE; Zhong N; Kaczmarski W; Kaczmarski A; Kida E; Brown WT; Schwarz KO; Lazzarini AM; Rubin AJ; Stenroos ES; Johnson WG; Wisniewski TM
    Ann Neurol; 1998 Jan; 43(1):106-10. PubMed ID: 9450775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coding sequence and exon/intron organization of the canine CLN3 (Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs.
    Shibuya H; Liu PC; Katz ML; Siakotos AN; Nonneman DJ; Johnson GS
    J Neurosci Res; 1998 May; 52(3):268-75. PubMed ID: 9590435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotyping heterozygous carriers of juvenile neuronal ceroid lipofuscinosis with CLN3 mutations.
    Bergholz R; Kohlschütter A; Schulz A; Hubert W; Rüther K
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1245-50. PubMed ID: 25338278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive Treatment for Retinal Degeneration in Juvenile Neuronal Ceroid Lipofuscinosis (Juvenile Batten Disease).
    Drack AV; Mullins RF; Pfeifer WL; Augustine EF; Stasheff SF; Hong SD
    Ophthalmic Genet; 2015; 36(4):359-64. PubMed ID: 24547931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular morphology and function in juvenile neuronal ceroid lipofuscinosis (CLN3) in the first decade of life.
    Preising MN; Abura M; Jäger M; Wassill KH; Lorenz B
    Ophthalmic Genet; 2017; 38(3):252-259. PubMed ID: 27486012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.